View More View Less
  • 1 Outpatient Institute of National Health Care Centre Róbert Károly körút 44 H-1134 Budapest Hungary
  • | 2 Medical Faculty, Semmelweis University 2nd Department for Internal Medicine Budapest Hungary
Restricted access

Non-alcoholic fatty liver disease is present in 15–25% of the general population. The fundamental derangement in non-alcoholic fatty liver disease is insulin resistance, a key component of the metabolic syndrome, which includes type 2 diabetes mellitus, dyslipidemia, hypertension, and obesity. The natural history of non-alcoholic fatty liver disease is not always benign, its causality for chronic liver disease and cirrhosis is well known in clinical practice and sometimes it is accompanied by hepatocellular carcinoma. Non-alcoholic fatty liver disease is likely to be associated with increased cardiovascular disease risk, and raises the possibility that non-alcoholic fatty liver disease may be not only a marker but also an early mediator of atherosclerosis. Therapy is currently directed at treating components of the metabolic syndrome which may also beneficial for the liver.

  • Adams, L. A., Lindor, K. D.: Nonalcoholic fatty liver disease. Ann. Epidemiol., 2007, 17 , 863–869.

    Lindor K. D. , 'Nonalcoholic fatty liver disease ' (2007 ) 17 Ann. Epidemiol. : 863 -869.

  • Akbar, D. H., Kawther, A. H.: Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we dont’t know. Med. Sci. Monit., 2006, 12 , 23–26.

    Kawther A. H. , 'Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we dont’t know ' (2006 ) 12 Med. Sci. Monit. : 23 -26.

    • Search Google Scholar
  • Targher, G., Bertolini, L., Padovani, R. et al.: Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabet. Care, 2007, 30 , 1212–1218.

    Padovani R. , 'Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients ' (2007 ) 30 Diabet. Care : 1212 -1218.

    • Search Google Scholar
  • Fraenkel, E., Takács, R., Hamvas, J. et al.: A nem alkoholos zsírmáj és az epekövesség együttes előfordulásának megfigyelése. (Common occurrence of non-alcoholic fatty liver and cholecystolithiasis.) (In Hungarian). Orv. Hetil., 2007, 148 , 793–798.

    Hamvas J. , 'A nem alkoholos zsírmáj és az epekövesség együttes előfordulásának megfigyelése. (Common occurrence of non-alcoholic fatty liver and cholecystolithiasis.) (In Hungarian) ' (2007 ) 148 Orv. Hetil. : 793 -798.

    • Search Google Scholar
  • Bogdanova, K., Poczatkova, H., Uherkova, L. et al.: Non-alcoholic fatty liver disease (NAFLD) – a novel common aspect of the metabolic syndrome. Biomed. Pap. Med. Fac. Univ. Papacky Olomouc Czech. Repub., 2006, 150 , 101–104.

    Uherkova L. , 'Non-alcoholic fatty liver disease (NAFLD) – a novel common aspect of the metabolic syndrome ' (2006 ) 150 Biomed. Pap. Med. Fac. Univ. Papacky Olomouc Czech. Repub. : 101 -104.

    • Search Google Scholar
  • Fehér, J., Németh, E., Lengyel, G.: Non-alcoholic steatohepatitis (NASH) – is it a part of the metabolic syndrome? Arch. Med. Sci., 2005, 1 , 37–47.

    Lengyel G. , 'Non-alcoholic steatohepatitis (NASH) – is it a part of the metabolic syndrome? ' (2005 ) 1 Arch. Med. Sci. : 37 -47.

    • Search Google Scholar
  • Musso, G., Gambino, R., Bo, S. et al.: Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? Diabet. Care, 2008, 31 , 562–568.

    Bo S. , 'Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? ' (2008 ) 31 Diabet. Care : 562 -568.

    • Search Google Scholar
  • Eiszrich, Á., Fehér, J.: Gyermekkori zsírmáj. (Fatty liver in childhood.) (In Hungarian). Orv., Hetil., 2007, 148 , 2461–2468.

    Fehér J. , 'Gyermekkori zsírmáj. (Fatty liver in childhood.) (In Hungarian) ' (2007 ) 148 Orv., Hetil. : 2461 -2468.

    • Search Google Scholar
  • Day, C. P., James, O. F. W.: Steatohepatitis: a tale of two ’hits’. Gastroenterology, 1998, 114 , 842–845.

    James O. F. W. , 'Steatohepatitis: a tale of two ’hits’ ' (1998 ) 114 Gastroenterology : 842 -845.

    • Search Google Scholar
  • Riley, P., O’Donohue, J., Crook, M.: A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease. J. Clin. Pathol., 2007, 60 , 1384–1391.

    Crook M. , 'A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease ' (2007 ) 60 J. Clin. Pathol. : 1384 -1391.

    • Search Google Scholar
  • Parekh, S., Anania, F. A.: Abnormal lipid and glucose metabolism in obesity: Implications for nonalcoholic fatty liver disease. Gastroenterology, 2007, 132 , 2191–2207.

    Anania F. A. , 'Abnormal lipid and glucose metabolism in obesity: Implications for nonalcoholic fatty liver disease ' (2007 ) 132 Gastroenterology : 2191 -2207.

    • Search Google Scholar
  • Tamura, S., Shimomura, I.: Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease. J. Clin. Invest., 2005, 115 , 1139–1142.

    Shimomura I. , 'Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease ' (2005 ) 115 J. Clin. Invest. : 1139 -1142.

    • Search Google Scholar
  • Browning, J. D., Horton, J. D.: Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest., 2004, 114 , 147–152.

    Horton J. D. , 'Molecular mediators of hepatic steatosis and liver injury ' (2004 ) 114 J. Clin. Invest. : 147 -152.

    • Search Google Scholar
  • Charlton, M., Sreekumar, R., Rasmussen, D. et al.: Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology, 2002, 35 , 898–904.

    Rasmussen D. , 'Apolipoprotein synthesis in nonalcoholic steatohepatitis ' (2002 ) 35 Hepatology : 898 -904.

    • Search Google Scholar
  • Cummings, M. H., Watts, G. F., Umpleby, A. M. et al.: Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetes, 1995, 44 , 1059–1065.

    Umpleby A. M. , 'Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM ' (1995 ) 44 Diabetes : 1059 -1065.

    • Search Google Scholar
  • Gaemers, I. C., Groen, A. K.: New insights in the pathogenesis of non-alcoholic fatty liver disease. Curr. Opin. Lipidol., 2006, 17 , 268–273.

    Groen A. K. , 'New insights in the pathogenesis of non-alcoholic fatty liver disease ' (2006 ) 17 Curr. Opin. Lipidol. : 268 -273.

    • Search Google Scholar
  • Wolfrum, C., Asilmaz, E., Luca, E. et al.: Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature, 2004, 432 , 1027–1032.

    Luca E. , 'Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes ' (2004 ) 432 Nature : 1027 -1032.

    • Search Google Scholar
  • Coppack, S. W.: Pro-inflammatory cytokines and adipose tissue. Proc. Nutr. Soc., 2001, 60 , 349–356.

    Coppack S. W. , 'Pro-inflammatory cytokines and adipose tissue ' (2001 ) 60 Proc. Nutr. Soc. : 349 -356.

    • Search Google Scholar
  • Saxena, N. K., Ikeda, K., Rockey, D. C. et al.: Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology, 2002, 35 , 762–771.

    Rockey D. C. , 'Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice ' (2002 ) 35 Hepatology : 762 -771.

    • Search Google Scholar
  • Hui, J. M., Hodge, A., Farrell, G. C. et al.: Beyond insulin resistance in NASH: TNF-α or adiponectin? Hepatology, 2004, 40 , 46–54.

    Farrell G. C. , 'Beyond insulin resistance in NASH: TNF-α or adiponectin? ' (2004 ) 40 Hepatology : 46 -54.

    • Search Google Scholar
  • Pagano, C., Soardo, G., Pilon, C. et al.: Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J. Clin. Endocrinol. Metab., 2006, 91 , 1081–1086.

    Pilon C. , 'Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance ' (2006 ) 91 J. Clin. Endocrinol. Metab. : 1081 -1086.

    • Search Google Scholar
  • Perseghin, G., Lattuada, G., De Cobelli, F. et al.: Serum resistin and hepatic fat content in non-diabetic individuals. J. Clin. Endocrinol. Metab., 2006, 91 , 5122–5125.

    Cobelli F. , 'Serum resistin and hepatic fat content in non-diabetic individuals ' (2006 ) 91 J. Clin. Endocrinol. Metab. : 5122 -5125.

    • Search Google Scholar
  • Graham, T. E., Yang, Q., Blüher, M. et al.: Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N. Engl. J. Med., 2006, 354 , 2552–2563.

    Blüher M. , 'Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects ' (2006 ) 354 N. Engl. J. Med. : 2552 -2563.

    • Search Google Scholar
  • Neuschwander-Tetri, B. A.: Fatty liver and metabolic syndrome. Curr. Opin. Gastroenterol., 2007, 23 , 193–198.

    Neuschwander-Tetri B. A. , 'Fatty liver and metabolic syndrome ' (2007 ) 23 Curr. Opin. Gastroenterol. : 193 -198.

    • Search Google Scholar
  • Fracanzani, A. L., Burdick, L., Rasselli, S. et al.: Risk of early atherosclerosis evaluated by carotid artery intima-media thickness in patients with non alcoholic fatty liver disease: a case-control study. Hepatology, 2005, 42 , 610A–1A.

    Rasselli S. , 'Risk of early atherosclerosis evaluated by carotid artery intima-media thickness in patients with non alcoholic fatty liver disease: a case-control study ' (2005 ) 42 Hepatology : 610A -1A.

    • Search Google Scholar
  • Villanova, N., Moscatiello, S., Ramilli, S. et al.: Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology, 2005, 42 , 473–478.

    Ramilli S. , 'Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease ' (2005 ) 42 Hepatology : 473 -478.

    • Search Google Scholar
  • Targher, G., Bertolini, L., Padovani, R. et al.: Increased prevalence of cardiovascular disease among type 2 diabetic patients with non-alcoholic fatty liver disease. Diabet. Med., 2006, 23 , 403–409.

    Padovani R. , 'Increased prevalence of cardiovascular disease among type 2 diabetic patients with non-alcoholic fatty liver disease ' (2006 ) 23 Diabet. Med. : 403 -409.

    • Search Google Scholar
  • Lin, Y. C., Lo, H. M., Chen, J. D.: Sonographic fatty liver, overweight and ischemic heart disease. World J. Gastroenterol., 2005, 11 , 4838–4842.

    Chen J. D. , 'Sonographic fatty liver, overweight and ischemic heart disease ' (2005 ) 11 World J. Gastroenterol. : 4838 -4842.

    • Search Google Scholar
  • Wannamethee, G., Ebrahim, S., Shaper, A. G. et al.: Gamma-glutamyltransferase: determinants and association with mortality from ischaemic heart disease and all causes. Am. J. Epidemiol., 1995, 142 , 699–708.

    Shaper A. G. , 'Gamma-glutamyltransferase: determinants and association with mortality from ischaemic heart disease and all causes ' (1995 ) 142 Am. J. Epidemiol. : 699 -708.

    • Search Google Scholar
  • Ruttmann, E., Brant, L. J., Concin, H. et al.: Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation, 2005, 112 , 2130–2137.

    Concin H. , 'Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults ' (2005 ) 112 Circulation : 2130 -2137.

    • Search Google Scholar
  • Ioannou, G. N., Weiss, N. S., Boyko, E. J. et al.: Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. Hepatology, 2006, 43 , 1145–1151.

    Boyko E. J. , 'Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States ' (2006 ) 43 Hepatology : 1145 -1151.

    • Search Google Scholar
  • Fehér, J., Lengyel, G.: A new approach to drug therapy in non-alcoholic steatohepatitis (NASH). J. Int. Med. Res., 2003, 31 , 537–551.

    Lengyel G. , 'A new approach to drug therapy in non-alcoholic steatohepatitis (NASH) ' (2003 ) 31 J. Int. Med. Res. : 537 -551.

    • Search Google Scholar
  • Watts, G. F., Gan, S. K.: Nutrition and metabolism: non-alcoholic fatty liver disease – pathogenesis, cardiovascular risk and therapy. Curr. Opin. Lipidol., 2008, 19 , 92–94.

    Gan S. K. , 'Nutrition and metabolism: non-alcoholic fatty liver disease – pathogenesis, cardiovascular risk and therapy ' (2008 ) 19 Curr. Opin. Lipidol. : 92 -94.

    • Search Google Scholar
  • Bende, J., Csiszár, M., Ursu, M.: Modern sebészi lehetőségek a nagyfokú elhízás kezelésében. (Modern surgical possibilities in the treatment of morbid obesity.) (In Hungarian). Orv. Hetil., 2003, 100 , 2459–2463.

    Ursu M. , 'Modern sebészi lehetőségek a nagyfokú elhízás kezelésében. (Modern surgical possibilities in the treatment of morbid obesity.) (In Hungarian) ' (2003 ) 100 Orv. Hetil. : 2459 -2463.

    • Search Google Scholar
  • De Alwis, N. M. W., Day, C., P.: Non-alcoholic fatty liver disease: The mist gradually clears. J. Hepatol., 2008, 48 , S104–S112.

    Day C., P. , 'Non-alcoholic fatty liver disease: The mist gradually clears ' (2008 ) 48 J. Hepatol. : S104 -S112.

    • Search Google Scholar
  • Hirose, A., Ono, M., Saibara, T. et al.: Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. Hepatology, 2007, 45 , 1375–1381.

    Saibara T. , 'Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis ' (2007 ) 45 Hepatology : 1375 -1381.

    • Search Google Scholar
  • Fehér, J., Sulyok, S., Várnai, K. et al.: The effect of a new synthetic dihydroquinoline type antioxidant in experimental atherosclerosis. Lipid Res., 1984, 4 , 20–26.

    Várnai K. , 'The effect of a new synthetic dihydroquinoline type antioxidant in experimental atherosclerosis ' (1984 ) 4 Lipid Res. : 20 -26.

    • Search Google Scholar
  • Lindor, K., Kowdley, K., Heathcote, E. et al.: Ursodeoxycholic acid for treatment of non alcoholic steatohepatitis: results of a randomized trial. Hepatology, 2004, 39 , 770–778.

    Heathcote E. , 'Ursodeoxycholic acid for treatment of non alcoholic steatohepatitis: results of a randomized trial ' (2004 ) 39 Hepatology : 770 -778.

    • Search Google Scholar
  • Dufour, J., Oneta, C., Gonvers, J. et al.: Swiss Association for the Study of the Liver: randomized placebo controlled trial of ursodeoxycholic acid with vitamin E in nonalcoholic steatohepatitis. Clin. Gastroenterol. Hepatol., 2006, 4 , 1537–1543.

    Gonvers J. , 'Swiss Association for the Study of the Liver: randomized placebo controlled trial of ursodeoxycholic acid with vitamin E in nonalcoholic steatohepatitis ' (2006 ) 4 Clin. Gastroenterol. Hepatol. : 1537 -1543.

    • Search Google Scholar
  • Satapathy, S., Sakhuja, P., Malhotra, V. et al.: Benefical effects of pentoxyfilline on hepatic steatosis, fibrosis and necroinflammation in patients with non alcoholic steatohepatitis. J. Gastroenterol. Hepatol., 2007, 22 , 634–638.

    Malhotra V. , 'Benefical effects of pentoxyfilline on hepatic steatosis, fibrosis and necroinflammation in patients with non alcoholic steatohepatitis ' (2007 ) 22 J. Gastroenterol. Hepatol. : 634 -638.

    • Search Google Scholar
  • SOng, J., Younossi, Z., Reddy, V. et al.: Cryptogenic cirrhosis and post-transplantation nonalcoholic fatty liver disease. Liver Transpl., 2001, 7 , 797–801.

    Reddy V. , 'Cryptogenic cirrhosis and post-transplantation nonalcoholic fatty liver disease ' (2001 ) 7 Liver Transpl. : 797 -801.

    • Search Google Scholar

Hungarian Medical Journal
Language English
Size  
Year of
Foundation
2007
Publication
Programme
ceased
Volumes
per Year
 
Issues
per Year
 
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1788-6139 (Print)
ISSN 1789-0403 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
May 2021 2 0 0
Jun 2021 2 0 0
Jul 2021 5 1 2
Aug 2021 5 0 0
Sep 2021 2 3 3
Oct 2021 0 2 2
Nov 2021 0 0 0